Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001104659-09-021781
Filing Date
2009-03-31
Accepted
2009-03-31 16:46:33
Documents
11
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a09-1330_110k.htm 10-K 1465956
2 EX-14.1 a09-1330_1ex14d1.htm EX-14.1 64492
3 EX-14.2 a09-1330_1ex14d2.htm EX-14.2 26188
4 EX-14.3 a09-1330_1ex14d3.htm EX-14.3 31263
5 EX-14.4 a09-1330_1ex14d4.htm EX-14.4 18211
6 EX-14.5 a09-1330_1ex14d5.htm EX-14.5 18989
7 EX-21.1 a09-1330_1ex21d1.htm EX-21.1 5349
8 EX-31.1 a09-1330_1ex31d1.htm EX-31.1 11670
9 EX-31.2 a09-1330_1ex31d2.htm EX-31.2 11545
10 EX-32.1 a09-1330_1ex32d1.htm EX-32.1 5108
11 EX-32.2 a09-1330_1ex32d2.htm EX-32.2 5222
  Complete submission text file 0001104659-09-021781.txt   1665585
Mailing Address 480 SOUTH HOLLY STREET DENVER CO 80246
Business Address 480 SOUTH HOLLY STREET DENVER CO 80246 303 336-1425
XELR8 HOLDINGS, INC. (Filer) CIK: 0001134765 (see all company filings)

EIN.: 841575085 | State of Incorp.: NV | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-32420 | Film No.: 09719632
SIC: 2833 Medicinal Chemicals & Botanical Products